High-containment manufacturing
Facility strategy, occupational controls, potent-compound handling, closed processing and operational readiness.
Zurich · September 13–15, 2027
ADC manufacturing, outsourcing and sterile fill-finish conference.
ADC NEXUS 2027 connects the organizations developing antibody-drug conjugates with the manufacturing, CDMO, equipment, quality and supply-chain partners required to move complex products from programme strategy to reliable commercial supply.
Why ADC manufacturing needs its own forum
Complex products create connected operational decisions.
Antibody-drug conjugates bring potent payloads, biologic complexity, containment requirements and sterile-product expectations into the same manufacturing pathway. Capacity alone is not enough; teams must evaluate capability, technology fit, quality systems, transfer readiness, supply resilience and commercialization timelines together.
ADC NEXUS is built around those interdependent decisions. It combines technical operating insight with structured access to developers, CDMOs and specialist solution providers across the ADC manufacturing ecosystem.
Conference focus
Across the ADC manufacturing lifecycle.
Sterile fill-finish
Aseptic processing, formulation, drug-product configuration, inspection, packaging and Annex 1 expectations.
CDMO and outsourcing strategy
Capability assessment, capacity, governance, contracting, make-versus-buy decisions and long-term partnership models.
CMC and technology transfer
Process characterization, analytical strategy, comparability, transfer planning, scale-up and validation.
Supply chain and cold chain
Materials, payload and linker coordination, logistics, temperature control, risk management and commercial continuity.
Commercial manufacturing
Launch readiness, network strategy, capacity expansion, lifecycle planning and investment decisions.
Who should attend
The ADC development and manufacturing value chain.
- ADC developers and pharmaceutical programme leaders
- CMC, manufacturing, technical-operations and quality executives
- CDMOs, CROs and specialist outsourcing partners
- Sterile fill-finish, equipment and containment providers
- Supply-chain, cold-chain, packaging and logistics teams
- Engineering, analytical, automation and technology companies
Event details
ADC NEXUS 2027 at a glance.
DatesSeptember 13–15, 2027
LocationZurich, Switzerland · venue to be announced
FormatThree-day conference and structured business partnering
What is ADC NEXUS 2027?
ADC NEXUS is a business and technical conference focused on antibody-drug conjugate manufacturing, high-containment operations, sterile fill-finish, outsourcing, CMC, supply chain and commercialization.
Who should attend an ADC manufacturing conference?
The programme is designed for ADC developers, pharmaceutical and biotechnology companies, CDMOs, CMC and manufacturing leaders, quality teams, supply-chain executives, equipment providers and technology partners.
Does the summit cover outsourcing and CDMO selection?
Yes. Outsourcing strategy, CDMO capability, capacity, technology transfer, quality, partnership models and make-versus-buy decisions are central to the ADC NEXUS programme.
Build the right manufacturing network
Connect ADC programmes with qualified operating partners.
Review registration categories or explore the conference agenda.